Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Pinto

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|September 23, 2021
The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus DiseaseAmelia K Pinto, Mariah Hassert, Xiaobing Han, et al.
Journal of Virology|July 10, 2015
Human and Murine IFIT1 Proteins Do Not Restrict Infection of Negative-Sense RNA Viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae FamiliesAmelia K Pinto, Graham D Williams, Kristy J Szretter, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccineMichael W Crawford, Walid M Abdelwahab, Karthik Siram, et al.
Iscience|August 19, 2022
Infection order outweighs the role of CD4<sup>+</sup> T cells in tertiary flavivirus exposureNicole Marzan-Rivera, Crisanta Serrano-Collazo, Lorna Cruz, et al.
NPJ Vaccines|July 16, 2025
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccineMichael W Crawford, Walid M Abdelwahab, Karthik Siram, et al.
Medrxiv : the Preprint Server for Health Sciences|June 8, 2021
Function is more reliable than quantity to follow up the humoral response to the Receptor Binding Domain of SARS- CoV-2 Spike protein after natural infection or COVID-19 vaccinationCarlos A Sariol, Petraleigh Pantoja, Crisanta Serrano-Collazo, et al.
Frontiers in Neuroscience|November 16, 2020
Human iPSC-Derived Neuronal Cells From <i>CTBP1</i>-Mutated Patients Reveal Altered Expression of Neurodevelopmental Gene NetworksS Vijayalingam, Uthayashanker R Ezekiel, Fenglian Xu, et al.
Cancer Immunology Research|December 11, 2020
Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient ObesityNiloufar Khojandi, Lindsey M Kuehm, Alexander Piening, et al.
Plos Neglected Tropical Diseases|May 29, 2020
Effective control of early Zika virus replication by Dengue immunity is associated to the length of time between the 2 infections but not mediated by antibodiesCrisanta Serrano-Collazo, Erick X Pérez-Guzmán, Petraleigh Pantoja, et al.
Nature Communications|June 24, 2017
Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virusPetraleigh Pantoja, Erick X Pérez-Guzmán, Idia V Rodríguez, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|September 23, 2021
The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus DiseaseAmelia K Pinto, Mariah Hassert, Xiaobing Han, et al.
Journal of Virology|July 10, 2015
Human and Murine IFIT1 Proteins Do Not Restrict Infection of Negative-Sense RNA Viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae FamiliesAmelia K Pinto, Graham D Williams, Kristy J Szretter, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccineMichael W Crawford, Walid M Abdelwahab, Karthik Siram, et al.
Iscience|August 19, 2022
Infection order outweighs the role of CD4<sup>+</sup> T cells in tertiary flavivirus exposureNicole Marzan-Rivera, Crisanta Serrano-Collazo, Lorna Cruz, et al.
NPJ Vaccines|July 16, 2025
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccineMichael W Crawford, Walid M Abdelwahab, Karthik Siram, et al.
Medrxiv : the Preprint Server for Health Sciences|June 8, 2021
Function is more reliable than quantity to follow up the humoral response to the Receptor Binding Domain of SARS- CoV-2 Spike protein after natural infection or COVID-19 vaccinationCarlos A Sariol, Petraleigh Pantoja, Crisanta Serrano-Collazo, et al.
Frontiers in Neuroscience|November 16, 2020
Human iPSC-Derived Neuronal Cells From <i>CTBP1</i>-Mutated Patients Reveal Altered Expression of Neurodevelopmental Gene NetworksS Vijayalingam, Uthayashanker R Ezekiel, Fenglian Xu, et al.
Cancer Immunology Research|December 11, 2020
Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient ObesityNiloufar Khojandi, Lindsey M Kuehm, Alexander Piening, et al.
Plos Neglected Tropical Diseases|May 29, 2020
Effective control of early Zika virus replication by Dengue immunity is associated to the length of time between the 2 infections but not mediated by antibodiesCrisanta Serrano-Collazo, Erick X Pérez-Guzmán, Petraleigh Pantoja, et al.
Nature Communications|June 24, 2017
Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virusPetraleigh Pantoja, Erick X Pérez-Guzmán, Idia V Rodríguez, et al.
Pageof 11